308 results for CRISPR
308 results for CRISPR
Delivery of CRISPR Ribonucleoproteins to Airway Epithelia Using Novel Amphiphilic PeptidesProject [Delivery Systems Initiative]![]() Show Experiments (6)
Testing Shuttle Peptides ability to deliver GFP-NLS to airway epithelia.
|
Enhancing CRISPR Gene Editing in Somatic Tissues by Chemical Modification of Guides and DonorsProject [Delivery Systems Initiative]![]() Show Experiments (11)
Testing newly chemically modified crRNA and tracrRNA in mTmG mouse embryonic fibroblasts
|
Enabling Nanoplatforms for Targeted in vivo Delivery of CRISPR/Cas9 Ribonucleoproteins in the Brain.Experiment - [In Vivo] [Delivery Systems Initiative] [Mouse] |
Develop Combinatorial Non-Viral and Viral CRISPR Delivery for Lung DiseasesProject [Delivery Systems Initiative]![]() |
Enabling Nanoplatforms for Targeted In Vivo Delivery of CRISPR/Cas9 Riboncleoproteins in the BrainProject [Delivery Systems Initiative]![]() |
[Validation] Independent validation of Gong delivery platform using RNP-loaded nanocages to deliver CRISPR/Cas9 to mouse brainExperiment - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
[Validation] Repeat experiment of independent validation of Chen delivery platform using LNPs to deliver CRISPR/Cas9 to mouse inner earExperiment - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
Comparing CRISPR/Cas9 gene editing efficencies between AAV9 and AAVcc47 in Ai9 mice with a 1:1 Cas9 to sgRNA ratio (CB promoter)Experiment - [In Vivo] [Delivery Systems Initiative] [Mouse] |
[Validation] Independent validation of Chen delivery platform using LNPs to deliver CRISPR/Cas9 to mouse inner earExperiment - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
Expanding CRISPR-Cas Editing Technology through Exploration of Novel Cas Proteins and DNA Repair SystemsProject [Genome Editors]![]() Show Experiments (1)
Testing newly discovered Biggie Phage editors in human cells
|
[Validation] Independent validation for McCray Delivery Team: Delivery of CRISPR Ribonucleoproteins to Airway Epithelia Using Novel Amphiphilic PeptidesExperiment - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
Comparing CRISPR/Cas9 gene editing efficiencies between AAV9 and AAVcc47 in Ai9 mice with a 1:3 Cas9 to sgRNA ratio (CMV promoter)Experiment - [In Vivo] [Delivery Systems Initiative] [Mouse] |
Comparing CRISPR/Cas9 gene editing efficencies between AAV9 and AAVcc47 in Ai9 mice with a 1:1 cas9 to sgRNA ratio (CMV promoter)Experiment - [In Vivo] [Delivery Systems Initiative] [Mouse] |
Comparing CRISPR/Cas9 gene editing efficencies between AAV9 and AAVcc47 in Ai9 mice with a 1:1 Cas9 to sgRNA ratio (CMV promoter) and self complementary sgRNA vector.Experiment - [In Vivo] [Delivery Systems Initiative] [Mouse] |
[Validation] Independent validation for Asokan Delivery Team: Evolving High Potency AAV Vectors for Neuromuscular Genome Editing.Experiment - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
Ai14 gRNAGuide - [In Vivo] [Small Animal Testing Center (SATC), Delivery Systems Initiative] [Mouse] |
Gong_Intracranial Injection Procedure for MiceProtocol - [In Vivo] [Delivery Systems Initiative] [Mouse] |
sg298Guide - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
RNP-NC-CPPDelivery System - [In Vivo] [Small Animal Testing Center (SATC), Delivery Systems Initiative] [Mouse] |
RNP-NC-no ligandDelivery System - [In Vivo] [Small Animal Testing Center (SATC), Delivery Systems Initiative] [Mouse] |
D237Delivery System - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
Murray-SATC_Gong-Validation Brain Injection in Mice ProtocolProtocol - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
Other Id:
ab104224Ā
Abcam, mouse anti-NeuN |
Other Id:
A21207
Invitrogen, Donkey anti-rabbit alexa fluor 594 |
Other Id:
A21202
Invitrogen, Donkey anti-mouse alexafluor 488 |
Ai14 mouseModel System - [In Vivo] [Delivery Systems Initiative] [Mouse] |
306-O12B blankDelivery System - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
D10Delivery System - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
Murray-SATC_Gong-Validaiton_Gong Study ProtocolProtocol - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
Other Id:
ab150155
Abcam, Donkey anti-rat alexa fluour 647 |
sNLS-SpCas9-sNLSGenome Editor - [In Vivo] [Small Animal Testing Center (SATC), Delivery Systems Initiative] [Mouse] |
SaCas9-LagorGenome Editor - [In Vivo] [Delivery Systems Initiative] [Mouse]Show Experiments (4)
Comparing CRISPR/Cas9 gene editing efficencies between AAV9 and AAVcc47 in Ai9 mice with a 1:1 Cas9 to sgRNA ratio (CB promoter)
|
[Validation] Independent validation of Deverman delivery platform using engineered AAVs to deliver CRSIPR/Cas9 to mouse brainExperiment - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
AAVcc47-Ai9-sgRNA1-CB-SaCas9Vector - [In Vivo] [Delivery Systems Initiative] [Mouse] |
AAVcc47-Ai9-sgRNA1 + sgRNA2Vector - [In Vivo] [Delivery Systems Initiative] [Mouse] |
AAVcc47-CMV-SaCas9Vector - [In Vivo] [Delivery Systems Initiative] [Mouse] |
CleanCapĀ® Cas9 mRNA (5moU)Genome Editor - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
AAV9-Ai9-sgRNA2-CB-SaCas9Vector - [In Vivo] [Delivery Systems Initiative] [Mouse] |
RNP-NC-RVGDelivery System - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
Heaney-SATC_McCray-Validation_Intranasal Instillation in Mice ProtocolProtocol - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
Other Id:
Rockland Cat# 600-401-379
Anti-RFP (RABBIT) Antibody |
AAV9-Ai9-sgRNA1 + sgRNA2Vector - [In Vivo] [Delivery Systems Initiative] [Mouse] |
AAV9_pTR_self comp 2xU6-Ai9 guidesVector - [In Vivo] [Delivery Systems Initiative] [Mouse] |
AAVcc47_pTR_self comp 2xU6-Ai9 guidesVector - [In Vivo] [Delivery Systems Initiative] [Mouse] |
AAVcc47-Ai9-sgRNA2-CB-SaCas9Vector - [In Vivo] [Delivery Systems Initiative] [Mouse] |
SpCas9Genome Editor - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
306-O12BDelivery System - [In Vivo, In Vitro] [Small Animal Testing Center (SATC), Delivery Systems Initiative] [Mouse]Show Experiments (5)
Repeat experiment of independent validation of Chen delivery platform using LNPs to deliver CRISPR/Cas9 to mouse inner ear
|
Ai9 mouseModel System - [In Vivo] [Small Animal Testing Center (SATC), AAV tropism, Delivery Systems Initiative] [Mouse]Show Experiments (10)
Testing gRNA sequence and gRNA scaffold modified in Ai9 mice.
|
306-S10Delivery System - [In Vivo, In Vitro] [Small Animal Testing Center (SATC), Delivery Systems Initiative] [Mouse]Show Experiments (4)
Independent validation of Chen delivery platform using LNPs to deliver CRISPR/Cas9 to mouse inner ear
|
Heaney_SATC Tissue Processing, Imaging and AnalysisProtocol - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse]Show Experiments (4)
Independent validation for Asokan Delivery Team: Evolving High Potency AAV Vectors for Neuromuscular Genome Editing.
|
FSD117D1Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
Gene editing in vitro by various peptide variants delivering Cas12a in NK cells.Experiment - [In Vitro] [Delivery Systems Initiative] [Human] |
Testing AAV5 for activation of tdTomato in HEK293T cellsExperiment - [In Vitro] [Delivery Systems Initiative] [Human] |
FS48Delivery System - [In Vitro] [Delivery Systems Initiative] [Human]Show Experiments (1)
Peptide Shuttle optimization to deliver Cas9 RNP to human airway epithelia cells
|
FSD118Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD168d10Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD168d20Delivery System - [In Vitro] [Delivery Systems Initiative] [Human]Show Experiments (1)
Peptide Shuttle optimization to deliver Cas12a RNP to human airway epithelia cells
|
FSD168D20Delivery System - [In Vitro] [Delivery Systems Initiative] [Human]Show Experiments (1)
Peptide Shuttle optimization to deliver Cas9 RNP to human airway epithelia cells
|
FSD168 Disul.Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD168 Scr.Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD216Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD234Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD260Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD288Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD293Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD315Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD329Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD333Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD364Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD57d5Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSX2Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSX6Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSX8Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
3849 45-5'Guide - [In Vitro] [Delivery Systems Initiative] [Human]Show Experiments (1)
Peptide Shuttle optimization to deliver Cas12a RNP to human airway epithelia cells
|
g-loxPbot_C12aGuide - [In Vivo] [Delivery Systems Initiative] [Mouse] |
sgAi9LGuide - [In Vivo, In Vitro] [Delivery Systems Initiative] [Human, Mouse] |
Antibody - [In Vivo] [Delivery Systems Initiative] [Mouse]Anti-RFP (RABBIT) Antibody Show Experiments (1) |
Shuttle peptides enable in vivo gene editing with Cas9 and Cas12a RNP in mouse airway epitheliaExperiment - [In Vivo] [Delivery Systems Initiative] [Mouse] |
Cre recombinaseGenome Editor - [In Vitro] [Delivery Systems Initiative] [Human]Show Experiments (1) |
FSD112Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD114d1Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD168d11Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD190Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD235Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD237Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD284Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD285Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD289Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD303Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD304Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD310Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD321Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD339Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD341Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD362Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD365Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD367Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD368Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD57d3Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD57d6Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD63Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD63D1Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSX3Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
pAAV.pU1a-SpCas9Vector - [In Vitro] [Delivery Systems Initiative] [Human]Show Experiments (1) |
g-loxP2_C9Guide - [In Vivo] [Delivery Systems Initiative] [Mouse] |
mTmG mouseModel System - [In Vivo] [Delivery Systems Initiative] [Mouse] |
Primary Airway Epithelia (Human)Model System - [In Vitro] [Delivery Systems Initiative] [Human] |
Antibody - [In Vivo] [Delivery Systems Initiative] [Mouse]Anti-CC10 (Rabbit) Polyclonal Antibody, dilution used 1:2,000 Show Experiments (1)
Testing AAV5 for activation of tdTomato in mouse airway club and ciliated cells
|
Gene editing in vitro by various peptide variants delivering Cas RNPs to primary Human airway epithelia cells.Experiment - [In Vitro] [Delivery Systems Initiative] [Human] |
Testing AAV5 for activation of tdTomato in mouse airwayExperiment - [In Vivo] [Delivery Systems Initiative] [Mouse] |
Alt-RĀ® S.p. Cas9 Nuclease V3Genome Editor - [In Vivo] [Delivery Systems Initiative] [Mouse] |
AsCas12a (Feldan Therapeutics)Genome Editor - [In Vitro] [Delivery Systems Initiative] [Human] |
SpCas9 (Feldan Therapeutics)Genome Editor - [In Vitro] [Delivery Systems Initiative] [Human] |
FS66d6Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD115d1Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD116d1Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD159Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD160Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD168d12Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD168d17Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD189Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD191Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD195Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD222Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD227Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD228Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD236Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD238Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD239Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD240Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD287Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD305Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD331Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD347Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD359Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD363Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD67Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD96Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSX1Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSX5Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSX7Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
S10DDelivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
sgAi9RGuide - [In Vivo, In Vitro] [Delivery Systems Initiative] [Human, Mouse] |
BALB/c mouseModel System - [In Vivo] [Delivery Systems Initiative] [Mouse]Show Experiments (1)
Testing Shuttle Peptides ability to deliver GFP-NLS to airway epithelia.
|
HEK-293T with Ai9 transient reporter assayModel System - [In Vitro] [Delivery Systems Initiative] [Human]Show Experiments (1) |
NKModel System - [In Vitro] [Delivery Systems Initiative] [Human]Show Experiments (1)
Gene editing in vitro by various peptide variants delivering Cas12a in NK cells.
|
Antibody - [In Vivo] [Delivery Systems Initiative] [Mouse]Anti-RFP (Mouse) Monoclonal Antibody, dilution used 1:300 Show Experiments (1)
Testing AAV5 for activation of tdTomato in mouse airway club and ciliated cells
|
Testing Shuttle Peptides ability to deliver GFP-NLS to airway epithelia.Experiment - [In Vivo] [Delivery Systems Initiative] [Mouse] |
FSD121Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD168 cyclicDelivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD193Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD196Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD199Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD215Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD259Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD262Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD283Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD291Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD301Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD306Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD307Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD308Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD316Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD322Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD334Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD366Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD57Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD97Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSX4Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
H509 AAVsc-u6-sgAI9L-U6-AI9R-U1A-EGFP (1)Vector - [In Vivo] [Delivery Systems Initiative] [Mouse] |
pH509 AAVsc-u6-sgAI9L-U6-AI9R-U1A-EGFP (1)Vector - [In Vitro] [Delivery Systems Initiative] [Human]Show Experiments (1) |
McCray_CFTR_Cas9_Guide1Guide - [In Vitro] [Delivery Systems Initiative] [Human]Show Experiments (1)
Peptide Shuttle optimization to deliver Cas9 RNP to human airway epithelia cells
|
Antibody - [In Vivo] [Delivery Systems Initiative] [Mouse]Anti-alpha Tubulin (Mouse) Monoclonal Antibody, dilution used 1:200 Show Experiments (1)
Testing AAV5 for activation of tdTomato in mouse airway club and ciliated cells
|
Antibody - [In Vivo] [Delivery Systems Initiative] [Mouse]Anti-RFP (Rabbit) Polyclonal Antibody Show Experiments (1)
Testing AAV5 for activation of tdTomato in mouse airway club and ciliated cells
|
S10Delivery System - [In Vivo, In Vitro] [Delivery Systems Initiative] [Human, Mouse]Show Experiments (7)
Testing Shuttle Peptides ability to deliver GFP-NLS to airway epithelia.
|
Delivery of chemically modified, phosphorothioate (PS)-stabilized crRNA with chemically modified, PS-stabilized tracrRNA to activate the mTmG reporter in mouse brainExperiment - [In Vivo] [Delivery Systems Initiative] [Mouse] |
Testing newly chemically modified crRNA and tracrRNA in mouse Neuro 2A cellsExperiment - [In Vitro] [Delivery Systems Initiative] [Mouse] |
STS118 (TLR-MCV1a; Sp_t2-PS:Sp_c20_TLR_MCV1a)Guide - [In Vivo] [Delivery Systems Initiative] [Mouse] |
STS120 (TLR1; Sp_t2:Sp_c20_TLR1)Guide - [In Vitro] [Delivery Systems Initiative] [Human] |
STS204 (DNMT1; Sp_t2:Sp_c20_Dnmt1)Guide - [In Vivo] [Delivery Systems Initiative] [Mouse] |
HEK-293T-disrupted_GFP-mcherry-PuroModel System - [In Vitro] [Delivery Systems Initiative] [Human] |
Delivery of unmodified, phosphorothioate (PS)-stabilized crRNA with chemically modified, PS-stabilized tracrRNA using the S10 shuttle peptide to activate the mTmG reporter in mouse brainExperiment - [In Vivo] [Delivery Systems Initiative] [Mouse] |
Delivery of chemically modified, phosphorothioate (PS)-stabilized crRNA with chemically modified, extended PS-stabilized tracrRNA to activate the mTmG reporter in mouse brainExperiment - [In Vivo] [Delivery Systems Initiative] [Mouse] |
STS119 (TLR-MCV1b; Sp_t2:Sp_c20_TLR_MCV1b)Guide - [In Vitro] [Delivery Systems Initiative] [Human] |
STS134 (PCSK9b; Sp_t2:Sp_c20_PCSK9b)Guide - [In Vitro] [Delivery Systems Initiative] [Mouse]Show Experiments (1)
Testing newly chemically modified crRNA and tracrRNA in mouse Hepa 1-6 cells
|
STS135 (PCSK9c; Sp_t2:Sp_c20_PCSK9c)Guide - [In Vitro] [Delivery Systems Initiative] [Mouse]Show Experiments (1)
Testing newly chemically modified crRNA and tracrRNA in mouse Hepa 1-6 cells
|
STS159 (mTmG; Sp_t2-PS:Sp_c20_mTmG)Guide - [In Vivo] [Delivery Systems Initiative] [Mouse] |
STS159 (mTmG; Sp_t2:Sp_c0_mTmG)Guide - [In Vivo] [Delivery Systems Initiative] [Mouse] |
STS204 (DNMT1; Sp_t41:Sp_c20_Dnmt1)Guide - [In Vitro] [Delivery Systems Initiative] [Mouse] |
Mouse Embryonic FibroblastsModel System - [In Vitro] [Delivery Systems Initiative] [Mouse] |
Lipofectamine 3000Delivery System - [In Vitro] [Genome Editors, Delivery Systems Initiative] [Human] |
Testing preparation for independent validation at The Jackson Laboratory Small Animal Testing CenterExperiment - [In Vivo] [Delivery Systems Initiative] [Mouse] |
STS118 (TLR-MCV1a; Sp_t2:Sp_c20_TLR_MCV1a)Guide - [In Vitro] [Delivery Systems Initiative] [Human] |
HEK-293T-disrupted_GFP with MCV-mcherry-PuroModel System - [In Vitro] [Delivery Systems Initiative] [Human] |
Delivery of unmodified, phosphorothioate (PS)-stabilized crRNA with chemically modified, extended PS-stabilized tracrRNA to activate the mTmG reporter in mouse brainExperiment - [In Vivo] [Delivery Systems Initiative] [Mouse] |
Testing newly chemically modified crRNA and tracrRNA to activate the TLR reporter in human cellsExperiment - [In Vitro] [Delivery Systems Initiative] [Human] |
Delivery of RNP containing chemically modified crRNA C20 with chemically modified tracrRNA T2-PS to determine the RNP distribution in TLR-MCV mouse brainExperiment - [In Vivo] [Delivery Systems Initiative] [Mouse] |
SpyCas9-3xNLSGenome Editor - [In Vivo, In Vitro] [Delivery Systems Initiative] [Human, Mouse]Show Experiments (6)
Testing newly chemically modified crRNA and tracrRNA in mTmG mouse embryonic fibroblasts
|
SpyCas9-3xNLSGenome Editor - [In Vivo] [Delivery Systems Initiative] [Mouse]Show Experiments (5)
Delivery of chemically modified, phosphorothioate (PS)-stabilized crRNA with chemically modified, PS-stabilized tracrRNA to activate the mTmG reporter in mouse brain
|
STS159 (mTmG; Sp_t2-PS:Sp_c0_mTmG)Guide - [In Vivo] [Delivery Systems Initiative] [Mouse] |
STS159 (mTmG; Sp_t2:Sp_c20_mTmG)Guide - [In Vivo, In Vitro] [Delivery Systems Initiative] [Mouse] |
STS159 (mTmG; Sp_t2:Sp_c20_mTmG)Guide - [In Vivo] [Delivery Systems Initiative] [Mouse] |
STS96 (PCSK9a; Sp_t2:Sp_c20_PCSK9a)Guide - [In Vitro] [Delivery Systems Initiative] [Mouse]Show Experiments (1)
Testing newly chemically modified crRNA and tracrRNA in mouse Hepa 1-6 cells
|
Hepa1-6Model System - [In Vitro] [Delivery Systems Initiative] [Mouse]Show Experiments (1)
Testing newly chemically modified crRNA and tracrRNA in mouse Hepa 1-6 cells
|
Neuro 2AModel System - [In Vitro] [Delivery Systems Initiative] [Mouse]Show Experiments (1)
Testing newly chemically modified crRNA and tracrRNA in mouse Neuro 2A cells
|
Other Id:
AB_1196615
GFP (D5.1) XP Rabbit mAb antibody, Cell Signaling Technology Show Experiments (3)
Testing preparation for independent validation at The Jackson Laboratory Small Animal Testing Center
|
Other Id:
AB_2798820
Cas9 (S. pyogenes) (E7M1H) XPĀ® Rabbit mAb antibody, Cell Signaling Technology |
Peptide Shuttle optimization to deliver Cas9 RNP to human airway epithelia cellsExperiment - [In Vitro] [Delivery Systems Initiative] [Human] |
Peptide Shuttle optimization to deliver Cas12a RNP to human airway epithelia cellsExperiment - [In Vitro] [Delivery Systems Initiative] [Human] |
Testing AAV5 for activation of tdTomato in mouse airway club and ciliated cellsExperiment - [In Vivo] [Delivery Systems Initiative] [Mouse] |
AsCas12a (IDT and Feldan Therapeutics)Genome Editor - [In Vivo] [Delivery Systems Initiative] [Mouse] |
GFP-NLSGenome Editor - [In Vivo] [Delivery Systems Initiative] [Mouse]Show Experiments (1)
Testing Shuttle Peptides ability to deliver GFP-NLS to airway epithelia.
|
FSD114Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD115Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD122Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD132Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD147Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD168Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD186Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD188Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD197Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD286Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD297Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD317Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD318Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD319Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD323Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD330Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD332Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD335Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD360Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD361Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD57d1Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD57d4Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD94Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD95Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
S10-MODDelivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
S10 Scr.Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
AAV.pU1a-SpCas9Vector - [In Vivo] [Delivery Systems Initiative] [Mouse] |
NKG2AGuide - [In Vitro] [Delivery Systems Initiative] [Human]Show Experiments (1)
Gene editing in vitro by various peptide variants delivering Cas12a in NK cells.
|
Antibody - [In Vivo] [Delivery Systems Initiative] [Mouse]GFP (D5.1) XP Rabbit mAb antibody Show Experiments (1) |
Ai14 mouse (congenic)Model System - [In Vivo] [Small Animal Testing Center (SATC), Delivery Systems Initiative] [Mouse]Show Experiments (4)
Repeat experiment of independent validation of Chen delivery platform using LNPs to deliver CRISPR/Cas9 to mouse inner ear
|
SpyCas9 g-loxP2_C9Guide - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
Heaney-SATC_McCray-Validation_Lung Inflation and Fixation ProtocolProtocol - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
Other Id:
13-0300Ā
Thermo-Fisher, Rat anti-GFAP |
Testing newly chemically modified crRNA and tracrRNA in mTmG mouse embryonic fibroblastsExperiment - [In Vitro] [Delivery Systems Initiative] [Mouse] |
Testing newly chemically modified crRNA and tracrRNA in mouse Hepa 1-6 cellsExperiment - [In Vitro] [Delivery Systems Initiative] [Mouse] |
Testing newly chemically modified crRNA and tracrRNA to activate the TLR1 reporter in human cellsExperiment - [In Vitro] [Delivery Systems Initiative] [Human] |
STS205 (BACE1; Sp_t41:Sp_c20_Bace1)Guide - [In Vitro] [Delivery Systems Initiative] [Mouse] |
TLR-MCV1 mouseModel System - [In Vivo] [Delivery Systems Initiative] [Mouse] |
Other Id:
AB_2536526
GFP Recombinant Rabbit Monoclonal Antibody, Thermo Fisher Scientific #G10362 Show Experiments (2)
Delivery of chemically modified, phosphorothioate (PS)-stabilized crRNA with chemically modified, PS-stabilized tracrRNA to activate the mTmG reporter in mouse brain
|
CasΦ-2Genome Editor - [In Vitro] [Genome Editors] [Human]Show Experiments (1)
Testing newly discovered Biggie Phage editors in human cells
|
Cas12j-GFP10 (CasΦ-3)Guide - [In Vitro] [Genome Editors] [Human]Show Experiments (1)
Testing newly discovered Biggie Phage editors in human cells
|
Cas12j-GFP11 (CasΦ-3)Guide - [In Vitro] [Genome Editors] [Human]Show Experiments (1)
Testing newly discovered Biggie Phage editors in human cells
|
Cas12j-GFP13 (CasΦ-3)Guide - [In Vitro] [Genome Editors] [Human]Show Experiments (1)
Testing newly discovered Biggie Phage editors in human cells
|
Cas12j-GFP15 (CasΦ-1)Guide - [In Vitro] [Genome Editors] [Human]Show Experiments (1)
Testing newly discovered Biggie Phage editors in human cells
|
Cas12j-GFP1 (CasΦ-1)Guide - [In Vitro] [Genome Editors] [Human]Show Experiments (1)
Testing newly discovered Biggie Phage editors in human cells
|
Cas12j-GFP7 (CasΦ-2)Guide - [In Vitro] [Genome Editors] [Human]Show Experiments (1)
Testing newly discovered Biggie Phage editors in human cells
|
Cas12j-GFP8 (CasΦ-2)Guide - [In Vitro] [Genome Editors] [Human]Show Experiments (1)
Testing newly discovered Biggie Phage editors in human cells
|
Cas12j-GFP9 (CasΦ-2)Guide - [In Vitro] [Genome Editors] [Human]Show Experiments (1)
Testing newly discovered Biggie Phage editors in human cells
|
SapI-GG stuffer (CasΦ-2)Guide - [In Vitro] [Genome Editors] [Human]Show Experiments (1)
Testing newly discovered Biggie Phage editors in human cells
|
SapI-GG stuffer (CasΦ-3)Guide - [In Vitro] [Genome Editors] [Human]Show Experiments (1)
Testing newly discovered Biggie Phage editors in human cells
|
CasΦ-1Genome Editor - [In Vitro] [Genome Editors] [Human]Show Experiments (1)
Testing newly discovered Biggie Phage editors in human cells
|
Cas12j-GFP14 (CasΦ-2)Guide - [In Vitro] [Genome Editors] [Human]Show Experiments (1)
Testing newly discovered Biggie Phage editors in human cells
|
Cas12j-GFP14 (CasΦ-3)Guide - [In Vitro] [Genome Editors] [Human]Show Experiments (1)
Testing newly discovered Biggie Phage editors in human cells
|
Cas12j-GFP3 (CasΦ-2)Guide - [In Vitro] [Genome Editors] [Human]Show Experiments (1)
Testing newly discovered Biggie Phage editors in human cells
|
Cas12j-GFP5 (CasΦ-3)Guide - [In Vitro] [Genome Editors] [Human]Show Experiments (1)
Testing newly discovered Biggie Phage editors in human cells
|
Cas12j-GFP6 (CasΦ-2)Guide - [In Vitro] [Genome Editors] [Human]Show Experiments (1)
Testing newly discovered Biggie Phage editors in human cells
|
Cas12j-GFP6 (CasΦ-3)Guide - [In Vitro] [Genome Editors] [Human]Show Experiments (1)
Testing newly discovered Biggie Phage editors in human cells
|
Cas12j-GFP7 (CasΦ-3)Guide - [In Vitro] [Genome Editors] [Human]Show Experiments (1)
Testing newly discovered Biggie Phage editors in human cells
|
AAV9-CMV-SaCas9Vector - [In Vivo] [Delivery Systems Initiative] [Mouse]Show Experiments (3)
Comparing CRISPR/Cas9 gene editing efficencies between AAV9 and AAVcc47 in Ai9 mice with a 1:1 cas9 to sgRNA ratio (CMV promoter)
|
CasΦ-3Genome Editor - [In Vitro] [Genome Editors] [Human]Show Experiments (1)
Testing newly discovered Biggie Phage editors in human cells
|
pPP441Vector - [In Vitro] [Genome Editors] [Human]Show Experiments (1)
Testing newly discovered Biggie Phage editors in human cells
|
pPP444Vector - [In Vitro] [Genome Editors] [Human]Show Experiments (1)
Testing newly discovered Biggie Phage editors in human cells
|
Cas12j-GFP10 (CasΦ-2)Guide - [In Vitro] [Genome Editors] [Human]Show Experiments (1)
Testing newly discovered Biggie Phage editors in human cells
|
Cas12j-GFP12 (CasΦ-3)Guide - [In Vitro] [Genome Editors] [Human]Show Experiments (1)
Testing newly discovered Biggie Phage editors in human cells
|
Cas12j-GFP1 (CasΦ-2)Guide - [In Vitro] [Genome Editors] [Human]Show Experiments (1)
Testing newly discovered Biggie Phage editors in human cells
|
Cas12j-GFP21 (CasΦ-1)Guide - [In Vitro] [Genome Editors] [Human]Show Experiments (1)
Testing newly discovered Biggie Phage editors in human cells
|
Cas12j-GFP23 (CasΦ-1)Guide - [In Vitro] [Genome Editors] [Human]Show Experiments (1)
Testing newly discovered Biggie Phage editors in human cells
|
Cas12j-GFP9 (CasΦ-3)Guide - [In Vitro] [Genome Editors] [Human] |